Items where authors include "Munir, T."

Article

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Rehman, A.U., Sharif, S., Hegazy, H.H. et al. (7 more authors) (2023) Low dielectric loss, and enhanced magneto-dielectric properties of Cu0.5Cd0.5-CoFe2O4 ferrites via Co2+ substitution. Materials Today Communications, 34. 105371. ISSN 2352-4928

Proceedings Paper

Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.

Pike, A., Richards, S.J., McKinley, C.E. orcid.org/0000-0003-4006-8846 et al. (8 more authors) (2023) Paroxysmal Nocturnal Haemoglobinuria (PNH) Arising from Non-Canonical Mutations. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, CA, USA. American Society of Hematology , p. 4097.

Pike, A., Fox, N., McKinley, C.E. orcid.org/0000-0003-4006-8846 et al. (22 more authors) (2023) Sars-Cov-2 Antibody and T-Cell Responses in Patients with Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia after Four COVID-19 Vaccinations. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, CA, USA. American Society of Hematology , p. 2712.